These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6441711)

  • 1. Pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients.
    Craig W
    Eur J Clin Microbiol; 1984 Dec; 3(6):575-8. PubMed ID: 6441711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo postantibiotic effect in a thigh infection in neutropenic mice.
    Vogelman B; Gudmundsson S; Turnidge J; Leggett J; Craig WA
    J Infect Dis; 1988 Feb; 157(2):287-98. PubMed ID: 3121761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
    Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
    J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models.
    Leggett JE; Ebert S; Fantin B; Craig WA
    Scand J Infect Dis Suppl; 1990; 74():179-84. PubMed ID: 2151487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in vitro susceptibility of veterinary antibiotics with human antibiotics within aminoglycosides, β-lactam and fluoroquinolone antibiotic classes to highly resistant Gram-negative pathogens from human medicine.
    Moore JE; Alcorn M; Rendall JC; Downey DG
    Br J Biomed Sci; 2015; 72(3):146-9. PubMed ID: 26510272
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of Pharmacodynamic Profiling for the Selection of Optimal β-lactam Regimens in a Large University Hospital.
    Koomanachai P; Yungyuen T; Disthaporn P; Kiratisin P; Nicolau DP
    Int J Infect Dis; 2016 May; 46():22-6. PubMed ID: 27021531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.
    Tam VH; Chang KT; Zhou J; Ledesma KR; Phe K; Gao S; Van Bambeke F; Sánchez-Díaz AM; Zamorano L; Oliver A; Cantón R
    J Antimicrob Chemother; 2017 May; 72(5):1421-1428. PubMed ID: 28158470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal antibiotic concentrations of aminoglycosides and beta-lactam antibiotics for some gram-negative bacilli and gram-positive cocci.
    Lorian V; De Freitas CC
    J Infect Dis; 1979 May; 139(5):599-603. PubMed ID: 108345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of inhibitory (MIC) and subinhibitory concentrations of tobramycin on bacteriostatic and bactericidal activities of beta-lactam antibiotics (author's transl)].
    Masuda G; Yajima T; Nakamura K; Yanagishita T; Yamazaki E
    Jpn J Antibiot; 1979 Nov; 32(11):1189-95. PubMed ID: 117156
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy.
    Auckenthaler R
    J Antimicrob Chemother; 2002 Jul; 50 Suppl():13-7. PubMed ID: 12077155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibiotic activity of 11 beta-lactam antibiotics in a cancer center.
    Landoy Z; Roisilin C; Surgalla MJ; Botzer R; Fitzpatrick JE; Blumenson LE
    J Surg Oncol; 1985 Sep; 30(1):23-5. PubMed ID: 3935872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.
    Vogelman B; Gudmundsson S; Leggett J; Turnidge J; Ebert S; Craig WA
    J Infect Dis; 1988 Oct; 158(4):831-47. PubMed ID: 3139779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lepak AJ; Zhao M; VanScoy B; Taylor DS; Ellis-Grosse E; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
    Landini G; Di Maggio T; Sergio F; Docquier JD; Rossolini GM; Pallecchi L
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7513-7517. PubMed ID: 27736757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postantibiotic suppression of bacterial growth.
    Bundtzen RW; Gerber AU; Cohn DL; Craig WA
    Rev Infect Dis; 1981; 3(1):28-37. PubMed ID: 6784225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans.
    Buxbaum A; Georgopoulos A
    Infection; 1996; 24(6):459-64. PubMed ID: 9007594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
    Odenholt-Tornqvist I
    Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.